Corneal transparency is dependent on the maintenance of the structural integrity and functional activity of its epithelial and endothelial limiting layers and the stroma. Different transient receptor potential (TRP) channel subtypes are expressed in cells and on corneal sensory nerve endings. They serve as sensors and transducers of environmental stimuli that can reduce tissue transparency. These nonselective cation channels are members of a superfamily sharing TRP box protein sequence homology having 6 membrane spanning domains with a pore between the fifth and sixth segments. TRP channels are composed of 4 monomeric subunits that oligomerize in homomeric or heteromeric configurations derived from different TRP subtypes belonging to the same or any of 6 different subfamilies. TRP subfamily members identified in the cornea include those belonging to the canonical, vanilloid, ankyrin, or melastatin subfamilies. In this review, we specifically focus on the functional roles of TRPV1 and TRPA1 expression in the cornea as their activation provides adaptive nociceptive and immune responses to noxious environmental stresses such as irritating ligands, temperature fluctuations, rises in ambient osmolarity, mechanical stretch, decline in pH, and tissue injury. Our previous studies have indicated that TRPV1 and TRPA1 subtypes are potential drug targets for improving corneal wound healing after alkali burns, because injury-induced fibrosis, neovascularization, and inflammation in either TRPV1 or TRPA1 gene-silenced mice were all significantly reduced.
FUNCTIONAL TRPV1 TISSUE EXPRESSION
Besides being expressed in all 3 corneal layers, functional transient receptor potential (TRP)V1 channels are also found throughout the human body, including in the peripheral nerve endings, brain, and spinal cord. This nonselective cationic Ca 2+permeable channel is activated at temperatures above 42°C and by a variety of environmental stresses such as chemicals (including capsaicin, resiniferatoxin, olvanil, and zingerone), exposure to hyperosmolarity, mechanical stretch, decline in pH levels below 6, and tissue injury resulting from the release and lysis of endogenous cellular constituents. Inflammatory mediators such as the eicosanoid 12-(S)-hydroperoxyeicosatetraenoic acid [12-(S) -HPETE] and leukotriene B4 can also elicit increases in intracellular Ca 2+ influx that activate the downstream signaling events leading to the modulation of a variety of gene expression events. Only a few of the very numerous reviews (.800) on this topic are listed here. [1] [2] [3] [4] [5] [6] [7] TRPV1 is also activated by a cannabinoid receptor type 1 (CB1) agonist, anandamide, through cross talk. 8, 9 TRPV1 channels are particularly important in the process of nociception. TRPV1 was first detected as the channel whose activation by capsaicin induces pain. It is also activated by moderate temperatures above 43°C, enabling us to sense and withdraw from noxious environmental conditions. 10, 11 In addition, TRPV1 can be sensitized by agents such as bradykinin and nerve growth factor (NGF) that are released from sites of tissue injury and act to increase the sensation of pain that characterizes hyperalgesia. 12 This hyperalgesic effect of bradykinin and NGF is mediated by the hydrolysis of PtdIns4,5P2, which normally inhibits TRPV1. 13, 14 In the urinary bladder, TRPV1 is expressed both in the afferent nerve terminals and in the epithelial cells lining the bladder lumen. 15 It seems to contribute to the stretch-evoked release of ATP that controls bladder function. It may also contribute to some bladder diseases. TRPV1 can be activated by the satiety factor oleoylethanolamide, but its action seems to require prior phosphorylation of the channel by protein kinase C. 16 
PHYSIOLOGICAL SIGNIFICANCE OF CORNEAL FUNCTIONAL TRPV1 EXPRESSION Epithelium
Functional TRPV1 expression is evident in the epithelial, stromal, and endothelial corneal tissue layers. 17 Its functional activity was first identified in human corneal epithelial cell (HCEC) and rabbit corneal epithelial cell lines, in their primary counterparts, and in human and mouse corneal epithelium in situ. 18 TRPV1 channel (capsaicin receptor) activation by this ligand increased nonselective cationic whole-cell currents (2.5-6 0.5-fold between 260 and 130 mV). These increases were accompanied by calcium transients that were fully blocked by the TRPV1 antagonist, capsazepine, or the removal of extracellular calcium. Downstream global mitogen-activated protein kinase transient superfamily activation induced 3.3-and 9-fold increases in interleukin (IL)-6 and IL-8 release, respectively. Subsequently, it was shown that this immune response was solely dependent on transient increases in JNK1/2 phosphorylation status. 19 This immune response to TRPV1 activation, induced by any of the aforementioned stresses in vivo, counters increases in stromal pathogenic infiltration caused by breaching of the corneal epithelial barrier function. Such a response has an adaptive value, provided that it is self-limiting and dysregulated. One indication that self-limiting TRPV1 activation has an adaptive value is that after epithelial debridement, reepithelialization occurs more slowly in TRPV1 genesilenced mice than in their age-matched wild-type (WT) counterparts. 20 There are also clear indications that TRPV1 activation by environmental stresses on afferent corneal sensory nerves contributes to nociception because TRPV1immunoreactive nerve fibers that display substance P and calcitonin gene-related peptide immunoreactivity are present on ophthalmic branches of the trigeminal nerve, which terminate in the rat corneal epithelium. 21 This finding, coupled with the identification of TRPV1 immunoreactivity in all layers of the rabbit corneal epithelium, strengthens the involvement of TRPV1 in mediating nociception, innate immune responses, and wound healing. 22 Furthermore, there is evidence that TRPV1 activation in HCECs can undergo downregulation as a consequence of CB1 coactivation. Concomitant CB1 activation reduces capsaicin-induced increases in Ca 2+ influx through an unknown mechanism which involves cross talk. This finding suggests the potential of CB1 as a drug target to moderate TRPV1 induction of innate immune responses. 9 FIGURE 1. Healing of alkali-burned corneas in TPV1 KO mice. A, The corneas of WT and KO mice at 1, 2, 5, 10, or 20 days. On each day, the incidence and degree of opacification in the burned cornea was more prominent in WT mice than in TRPV1 KO mice. At day 20, the iris was observed through the transparent cornea of KO mice but not WT mice. B, Evaluation of diameter alterations of the eyeball during wound healing after alkali burn showed that WT globes have a smaller diameter at 20 days than do KO globes. C, Histology of burned corneas that were stained with hematoxylin and eosin (HE) and immunohistochemical findings at days 5 and 20. HE staining showed that the burned cornea exhibits a higher cell population and more severely disorganized tissue in WT corneas than in KO tissues on days 5 and 20. The stroma was thicker in WT corneas than in KO corneas throughout the healing interval examined. Immunohistochemistry suggested that the density of myeloperoxidase (MPO)-labeled cells at day 5 and F4/80-labeled cells at day 20 was greater in WT corneas than in KO corneas. Healing burned corneas contained many a-smooth muscle actin-positive myofibroblasts in WT mice at days 5 and 20. However, the majority of corneal fibroblasts were not labeled with anti-aSMA antibody in TRPV1 KO mice. Scale bar = 100 mm. D, Real-time polymerized chain reaction (RT-PCR) also showed that the loss of TRPV1 suppressed mRNA expression levels of MPO, F4/80 and aSMA during wound healing after alkali burn. Data represent mean 6 standard error of the mean (SEM) from 5 specimens in each condition. *P , 0.05, bar = mean 6 SEM. Reprinted from Okada et al 24 with permission from Elsevier. Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.
Stroma
Functional TRPV1 expression is present in stromal fibroblasts based on capsaicin-induced transient increases in intracellular Ca 2+ levels associated with rises in underlying ionic currents. 23 Such responses elicited increases in proinflammatory cytokine release coupled with myofibroblast transdifferentiation based on increases in a-smooth muscle expression and phenotypic changes. In another mouse corneal wound-healing study, chemical burn-induced TRPV1 activation in all corneal tissue layers elicited fibrosis, dysregulated inflammation, neovascularization, and opacification ( Fig. 1 ). 24 TRPV1 involvement in these sight-compromising responses to severe injury is evident, because the wound-healing response in TRPV1 knockout (KO) mice was more favorable due to significantly less neovascularization, fibrosis, and reduced proinflammatory cytokine gene expression. Reciprocal bone marrow transplantation between mice showed that KO corneal tissue resident cells, but not KO bone marrow-derived cells, were responsible for KO mouse wound healing that occurred with reduced vascular fragility, inflammation, and fibrosis. Furthermore, similar wound-healing improvements were achieved by repeated intraperitoneal injections of a TRPV1 antagonist for 20 days after chemical injury. The complexity of TRPV1 involvement has become more evident because its interaction with transforming growth factor b-1 (TGFb-1)-mediated signaling leads to fibrosis. 25 Injuryinduced stromal fibrosis depends on epithelial derived TGFb-1 gaining stromal access. This occurs once an injury is sufficiently severe to breach the basement membrane barrier preventing the permeation of TGFb-1 into deeper layers of the stroma. TGFb-1 mediates these sight-compromising responses in vivo through the FIGURE 2. Healing of alkali-burned corneas in WT and TPA1-KO mice. A, The corneas of WT and KO mice at 5, 10, and 20 days. At each time point, the incidence and degree of opacification and surface irregularity in the healing cornea was more prominent in WT mice than in TRPA1 KO mice. B, Evaluation of diameter changes in the eyeball during healing from an alkali burn showed that WT globes had a smaller diameter than KO globes at 20 days. C, Hematoxylin and eosin (HE) histology and immunohistochemical findings of burned corneas at day 10. HE staining showed that the burned cornea exhibited a larger cell population (presumed inflammatory cells) and more severely disorganized tissue in WT corneas than in KO corneas. The stroma was thicker in WT corneas than in KO corneas throughout the healing period examined. Immunohistochemistry findings suggested the densities of myeloperoxidase (MPO)-labeled polymorphonuclear leukocytes (PMNs) and F4/80-labeled macrophages were greater in the WT cornea than in the KO cornea. Healing burned corneas in WT mice contained many a-smooth muscle actin (aSMA)-positive myofibroblasts. However, majority of corneal fibroblasts were not labeled with anti-aSMA antibody in KO mice. Expression of active transforming growth factor b1 (TGFb1) protein was greater in the WT stroma than in the KO stroma. Scale bar = 100 mm. D, Real-time polymerized chain reaction (RT-PCR) showed that lacking TRPA1 suppressed mRNA expression levels of MPO, F4/80, aSMA, and TGFb1 in a healing post-alkaliburned cornea. Data represent mean 6 standard error of the mean from 5 specimens in each condition (bar). *P , 0.05. Reprinted from Okada et al 30 with permission from Nature Publishing Group. Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.
TGFb receptor-mediated activation of TRPV1. This dependence on TRPV1 activation is required for eliciting Ca 2+signaling events to establish a recurrent loop of downstream kinase phosphorylations that sufficiently extend their residency in an activated state, long enough to upregulate gene expression events that drive myofibroblast development. Taken together, there is evidence to show that TRPV1 mediates the establishment of a recurrent loop that extends the length of signaling events in an activated state, which is required to drive myofibroblast development. Overall, understanding TRPV1 involvement in mediating TGFb-1-induced fibrosis supports the idea that suppressing stromal TRPV1 activation, subsequent to a severe corneal insult, can reduce fibrosis, dysregulated inflammation activation, and neovascularization.
Endothelium
Some TRPV family members are thermosensitive over a broad range of temperatures. TRPV1 begins to undergo activation once the temperature reaches 43°C. Cultured HCEC lines and limbal explants show TRPV1 immunoreactivity. TRPV1 has a functional role in this layer based on increased ionic currents underlying Ca 2+ transients, which is induced by either capsaicin or raising the temperature to 43°C. However, there is no definite information regarding its possible involvement in mediating responses that affect the endothelium in maintaining corneal deturgescence and transparency. 26 
FUNCTIONAL TRPA1 TISSUE EXPRESSION
TRPA1 is a member of the ankyrin subfamily and functions as a nonselective cation channel that is permeable to Ca 2+ , Na + , and K + . It is present in a subpopulation of Ad-and C-fiber nociceptive sensory neurons and in other sensory cells including epithelial cells. On hair cells, it may be essential for mechanotransduction, which is required for hearing. This TRP subtype is a promiscuous chemical nocisensor that is also involved in noxious cold and mechanical sensation. It responds to a number of pungent components such as isothiocyanates (found in horseradish), allicin (found in garlic), and cinnamaldehyde (found in cinnamon). In addition to being activated by cysteine-and lysine-reactive electrophiles and oxidants, TRPA1 is indirectly activated by proinflammatory molecules through the phospholipase C-signaling pathway, in which cytosolic Ca 2+ is an important regulator of channel gating. Evidence indicates that TRPA1 might contribute to touch hypersensitivity that develops during inflammation of the skin and plays an important role in histamine-insensitive itch neurons. TRPA1 also acts as a cold sensor by undergoing activation once the temperature falls below 17°C. TRPA1 is a polymodal sensor that functions in mechanosensation and temperature and pain sensing. Mutations of TRPA1 have been linked to familial episodic pain syndrome. TRPA1 is a promising drug target for novel treatments of pain, itch, and sensory hyperreactivity in visceral organs including the airways, bladder, and gastrointestinal tract. 27, 28 PHYSIOLOGICAL SIGNIFICANCE OF CORNEAL FUNCTIONAL TRPA1 EXPRESSION
Stroma
Several lines of evidence suggest that TRPA1 and TRPV1 mutually control the transduction of inflammation-induced noxious stimuli in sensory neurons. 29 Based on these indications, it was recently shown that TRPV1 influences the intrinsic characteristics of the TRPA1 channel. Subsequent to our identification of the importance of TRPV1 functional expression in mediating TGFb-1-driven fibrosis and inflammation, we recently reported that TRPA1 is also required for TGF-b signaling because its loss blocks corneal inflammatory fibrosis. TRPA1 involvement is evident because alkali-burned stroma undergoing healing were more transparent in TRPA1 (2/2) KO mice compared with their age-matched WT mice. Eye globe FIGURE 3 . Healing an alkali-burned cornea in a bone marrow transplanted (BMT) mouse. A, Ten and 20 days after alkali burning, a WT mouse that received bone marrow (BM) from a WT mouse (WT/WT) and a WT mouse that received BM from a TRPA1-KO mouse (KO/WT) exhibited greater opacification and neovascularization than a KO mouse that received BM from a WT mouse (WT/KO). B, Hematoxylin and eosin histology showed increased cell density in the swollen stroma in a KO/WT cornea than in a WT/KO cornea. Immunohistochemistry indicated the cornea of a WT/KO mouse had less stromal a-smooth muscle actin (aSMA) staining and lower levels of immunoreactivity for myeloperoxidase, F4/80, and active transforming growth factor b1 (TGFb1) than KO/WT tissues. Scale bar = 100 mm. Reprinted from Okada et al 30 with permission from Nature Publishing Group. Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation. diameters shrank more in the WT mice than in the KO mice, consistent with increased WT myofibroblast transdifferentiation compared with KO myofibroblasts. TRPA1 loss suppressed post-alkali burn inflammation, neovascularization, and fibrosis/ scarring as indicated by histology, immunohistochemistry, and gene expression analyses (Fig. 2) . Reciprocal bone marrow transplantation between mice showed that KO corneal tissue cells, but not KO bone marrow-derived cells, were responsible for KO mouse wound healing that occurred with reduced vascular fragility, inflammation, and fibrosis (Fig. 3) . Because systemic TRPA1 antagonist administration had similar effects to those induced in an earlier study, in which TRPV1 antagonists also reduced these responses to alkali-induced corneal burning, this finding supports the hypothesis that TRPA1 and TRPV1 interact with each other during wound healing (Fig. 4) . 24, 30 
SUMMARY, CONCLUSIONS, AND FUTURE DIRECTIONS
Our studies identified 2 novel potential therapeutic targets to treat sight-compromising corneal injuries that were caused by chemical burn in mice. In these targets, TRPV1 and TRPA1, chronic immune responses, neovascularization, and stromal fibrosis in gene-silenced littermates were all significantly attenuated, resulting in enhanced wound healing (Fig. 5 ). However, the wound-healing response to epithelial debridement was delayed in TRPV1 gene-silenced mice because transient TRPV1 activation in WT mice promoted cell proliferation and migration. These diametrically opposed FIGURE 4 . Treatment of corneal alkali burn in WT mice with a TRPA1 antagonist (HC-030031). A, The corneas of WT mice treated with or without HC-030031 at 5, 10, or 20 days. At each time point, corneal transparency restoration was markedly improved in mice treated with HC-030031. At day 20, the iris was seen through the transparent cornea in an antagonist-treated mouse, but not in an untreated mouse. B, Evaluation of changes in eyeball diameter during wound healing from an alkali burn showed that untreated globes had a smaller diameter at 20 days than did antagonist-treated globes. C, Histology of burned corneas stained with hematoxylin and eosin (HE) and immunohistochemical findings at day 10. The stromal organization was poorer in untreated mice than in antagonist-treated mice. The antagonist-treated mice had lower infiltration levels for myeloperoxidase-labeled neutrophils and F4/80-positive macrophages, in addition to marked a-smooth muscle actin (aSMA) and active transforming growth factor b1 (TGFb1) staining at both time points. Scale bar = 100 mm. Reprinted from Okada et al 30 with permission from Nature Publishing Group. Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation. effects on wound-healing rapidity make it problematic to design new therapies that selectively activate epithelial TRPV1 channels to accelerate reepithelialization, and inhibit stromal TRPV1 activation and suppress chronic inflammation and fibrosis. Meaningful therapeutic product development will depend on delineating specific sites on TRP channel structures that elicit each of these very different effects. Another challenge is to design agents free of side effects because the systemic inhibition of TRPV1 with capsazepine causes increases in body temperature, even if it inhibits inflammation and myofibroblast differentiation, thus leading to fibrosis. Currently, efforts are underway to identify site-specific domains on TRP channels whose occupancy induces a specific response.
